Anixa Biosciences (ANIX) Operating Leases (2020 - 2026)
Anixa Biosciences (ANIX) recorded Operating Leases of $128,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), down 26.4% from $174,000 a year earlier and down 8.6% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Anixa Biosciences reported Operating Leases of $163,000, down 19.7% from FY2024.
- Annual Operating Leases has a four-year compound annual growth rate of -7.2% (FY2021 to FY2025).
- Across earlier fiscal years, Operating Leases came in at $203,000 in FY2024 (+65.0%), $123,000 in FY2023 (-29.7%), $175,000 in FY2022 (-20.5%) and $220,000 in FY2021.
- The fiscal Q3 2026 figure is the lowest quarterly Operating Leases since fiscal Q2 2024.
- On a year-over-year basis, Operating Leases rose in three of the last seven quarters, with growth averaging 22.0%.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 97.8% in fiscal Q2 2025, against a decline of 37.6% in fiscal Q2 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Anixa Biosciences | 96.15 Mn | 81.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 128,000.00 |
| Apr 30, 2026 | 140,000.00 |
| Oct 31, 2025 | 163,000.00 |
| Jul 31, 2025 | 174,000.00 |
| Apr 30, 2025 | 184,000.00 |
| Jan 31, 2025 | 194,000.00 |
| Oct 31, 2024 | 203,000.00 |
| Jul 31, 2024 | 213,000.00 |
| Apr 30, 2024 | 93,000.00 |
| Jan 31, 2024 | 108,000.00 |
| Oct 31, 2023 | 123,000.00 |
| Jul 31, 2023 | 136,000.00 |
| Apr 30, 2023 | 149,000.00 |
| Jan 31, 2023 | 162,000.00 |
| Oct 31, 2022 | 175,000.00 |
| Jul 31, 2022 | 187,000.00 |
| Apr 30, 2022 | 202,000.00 |
| Jan 31, 2022 | 209,000.00 |
| Oct 31, 2021 | 220,000.00 |
| Jul 31, 2020 | 10,567.00 |
API Access
Anixa Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();